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The integral membrane protein flavocytochrome b (Cyt b) comprises the catalytic core of the human phagocyte NADPH oxidase complex
and serves to initiate a cascade of reactive oxygen species that participate in the elimination of infectious agents. Superoxide production by
the NADPH oxidase complex has been shown to be specifically regulated by the enzymatic generation of lipid second messengers following
phagocyte activation. In the present study, a Cyt b-specific monoclonal antibody (mAb 44.1) was labeled with Cascade Blue (CCB) and used
in resonance energy transfer (RET) studies probing the effects of a panel of lipid species on the structure of Cyt b. The binding of CCB-mAb
44.1 to immunoaffinity-purified Cyt b was both highly specific and resulted in significant quenching of the steady state donor fluorescence.
Titration of the CCB-mAb 44.1:Cyt b complex with the anionic amphiphile lithium dodecyl sulfate (LDS) resulted in a saturable relaxation of
fluorescence quenching due to conformational changes in Cyt b at concentrations of the amphiphile required for maximum rates of
superoxide production by Cyt b in cell-free assays. Similar results were observed for the anionic amphiphile arachidonic acid (AA), although
no relaxation of fluorescence quenching was observed for arachidonate methyl ester (AA-ME). Saturable relaxation of fluorescence
quenching was also observed with the anionic, 18:1 phospholipids phosphatidic acid (DOPA) and phosphatidylserine (DOPS), while no
relaxation was observed upon addition of the neutral 18:1 lipids phosphatidylcholine (DOPC), phosphatidylethanolamine (DOPE) or
diacylglycerol (DAG) at similar levels. Further examination of a variety of phosphatidic acid (PA) species demonstrated DOPA to both
potently induce conformational changes in Cyt b and to cause more dramatic conformational changes than PA species with shorter, saturated
acyl chains. The data presented in this study support the hypothesis that second messenger lipids, such as AA and PA, directly bind to
flavocytochrome b and modulate conformational states relevant to the activation of superoxide production.
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N-terminus and amidated at the C-terminus; CCB, Cascade Blue; Cyt b, human
phagocyte flavocytochrome b; DAG, diacylglycerol; DDM, dodecylmaltoside;
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In response to inflammatory stimuli, human phagocytes
migrate to sites of infection and tissue injury where they are
activated to release toxic proteins, hydrolytic enzymes and
reactive oxygen species [1]. The generation of reactive
oxygen species is initiated by the phagocyte NADPH com-
plex, which catalyzes the one electron reduction of molecular
oxygen to generate superoxide anion. The resulting superox-
ide anion serves as a precursor for the generation of toxic
oxygen species such as hydrogen peroxide, hydroxyl radical
and hypochlorous acid [2]. Flavocytochrome b (Cyt b) is a
heterodimeric, integral membrane protein composed of a
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(gp91phox) and a 195-residue subunit (p22phox) that serves
as the central, catalytic core of the NADPH oxidase complex
[1,3]. Cyt b has been characterized as a flavoprotein [4–6]
that coordinates two heme prosthetic groups [7–9] and
contains all of the structural determinants required for transfer
of metabolic electrons from NADPH across the plasma or
phagosomal membrane for reduction of molecular oxygen
[4,10]. Since reactive oxygen species have the capacity to
damage healthy host tissue when generated in an inappropri-
ate fashion, electron transfer through Cyt b is subject to strict
spatial and temporal regulation. Following activation of
phagocytes by inflammatory stimuli, the regulatory proteins
p47phox, p67phox, p40phox, and Rac 1/2 translocate to the
membrane and associate with flavocytochrome b to form
the multicomponent, catalytically active NADPH oxidase
complex [1,3,11].
Two prominent signal transduction events, namely the
phosphorylation of oxidase components and the generation
of lipid second messengers, have been shown to promote the
assembly and activation of the NADPH oxidase complex
following receptor-mediated activation of phagocytic cells
[11,12]. Although second messenger lipids including arach-
idonic acid (AA), phosphatidic acid (PA) and diacylglycerol
(DAG) have a well-defined role in signal transduction events
that lead to phosphorylation of oxidase components [12],
detailed investigation has also demonstrated the direct action
of such biologically active lipids on both the membrane-bound
and cytosolic components of the NADPH oxidase complex.
AA and PA have been shown to disrupt an interaction
between the small G protein Rac and (Rho)GDI, allowing
Rac to translocate from the cytosol to the membrane
environment where it would be available for assembly into
the NADPH oxidase complex [13]. In addition, a variety of
observations have demonstrated the ability of AA to induce
conformational changes in p47phox important for oxidase
assembly and activation. Spectroscopic analysis of purified
p47phox in the presence of the anionic amphiphiles lithium
dodecyl sulfate (LDS) and AA demonstrated the ability of
these agents to induce conformational changes analogous to
those induced by in vitro phosphorylation by protein kinase
C [14–16]. The conformational changes in p47phox brought
about by treatment with anionic amphiphiles were both
specific and occurred at levels that are required for maximal
rates of superoxide production by the NADPH oxidase
complex in in vitro cell-free assay systems. Further exam-
ination of the effects of AA on p47phox revealed that the
conformational changes induced by this amphiphile serve to
unmask the SH3 domains that mediate an interaction with a
proline rich region in the small subunit of flavocytochrome
b during oxidase assembly [17,18]. In addition, DAG and
PA have been shown to promote assembly and activation of
the NADPH oxidase complex [19–21], while PA alone has
been demonstrated sufficient to induce conformational
changes in p47phox [19]. How these amphipathic lipids are
transported from membranes to such cytoplasmic targetshas yet to be resolved. An alternative view has been
presented that suggests that anionic lipids predominantly
serve as an ionic matrix in the membrane to attract, bind
and facilitate the diffusion of Rac/p67phox complexes to Cyt
b [22,23].
Evidence has also been generated to suggest that second
messenger lipids interact directly with the integral mem-
brane flavocytochrome b to promote assembly and/or
activation of the NADPH oxidase complex. Following
detergent extraction of pig neutrophil membranes, super-
oxide production was elicited upon addition of PA (in the
absence of cytosolic oxidase factors) at levels similar to
those observed when the detergent extracts were combined
with cytosol and AA [24]. Similarly, PA was shown to
support optimal superoxide production and enhanced bind-
ing of the flavin cofactor of purified flavocytochrome b in
the absence of the cytosolic oxidase components [4,10]. In
studies characterizing the effects of AA on flavocyto-
chrome b, spectroscopic methods were used to demonstrate
that this agent induced a change in the heme environment
of both membrane-bound and detergent-solubilized Cyt b
[25]. In addition, our group has recently employed CCB-
labeled wheat germ agglutinin (WGA) as a donor for
fluorescence resonance energy transfer (FRET) experiments
demonstrating the ability of AA to induce structural
changes in detergent-solubilized Cyt b [26]. Thus, evidence
exists that the cytosolic oxidase components Rac and
p47phox and the integral membrane component Cyt b may
be directly regulated by physiologically generated lipid
second messengers.
In the present study, we have extended our previous
observations by Cascade Blue (CCB) labeling a Cyt b-
specific, epitope-mapped monoclonal antibody (mAb) and
using it as a more highly defined probe for investigating
structural rearrangements of purified Cyt b by FRET
[27,28]. Using this resonance energy transfer (RET) assay,
a panel of phospholipids and amphiphiles were examined
for the ability to induce conformational changes in deter-
gent-solubilized flavocytochrome b.2. Methods and materials
2.1. Materials
Dodecylmaltoside (DDM) was purchased from Fluka and
octylglucoside, PMSF and DTT from Calbiochem. Cascade
Blue acetyl azide and the anti-CCB rabbit polyclonal
antibody were from Molecular Probes. LDS, AA, arachid-
onate methyl ester (AA-ME), sodium deoxycholate, chy-
mostatin, the mammalian protease inhibitor cocktail
(P8340), HEPES and Tris were obtained from Sigma.
Protein A-Sepharose and GammaBind Plus-Sepharose
beads were from Pharmacia; Centricon-30 concentrators
from Millipore and the goat-anti mouse (H +L) alkaline
phosphatase secondary antibody and Econo-Pac 10 DG
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color molecular weight markers were purchased from
BMA; Western blot developing reagents were purchased
from Kirkegaard & Perry Laboratories and nitrocellulose
(0.45 Am pore size) was from Schleicher & Schuell. The
elution peptide AC-PQVRPI-CONH2 (AC-, acetylation at
the N-terminus of the elution peptide; -CONH2, amidation
at the C-terminus of the elution peptide) was obtained from
Macromolecular Resources. SDS, 0.2-Am polyethersulfone
syringe filters (Whatman), acrylamide, bis-acylamide, NaCl,
NaH2PO4, KCl, EDTA, EGTA, NaN3, chloroform and
HPLC grade methanol were from Fisher Scientific. The
synthetic phospholipids 1,2-dioctanoyl-sn-glycero-3-phos-
phate (8:0 PA), 1,2-distearoyl-sn-glycero-3-phosphate
(18:0 PA), 1,2-dioleoyl-sn-glycero-3-phosphate (18:1 PA),
1,2-dioleoyl-sn-glycero-3-[phospho-L-serine] (18:1 PS),
1,2-dioleoyl-sn-glycero-3-phosphocholine (18:1 PC), 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (18:1 PE),
1,2-dioctanoyl-sn-glycerol (8:0 DAG) and 1,2-dioleoyl-sn-
glycerol (18:1 DAG) were purchased from Avanti Polar
Lipids, Inc. The BCA protein determination kit and Reacti-
Vial Small Reaction Vials (used for storing chloroform-
solubilized lipids) were obtained from Pierce, while mAb
44.1 was produced in-house by standard hybridoma culture
methods.
Absorption measurements were performed on an Agi-
lent absorption spectrophotometer with quartz cuvettes
obtained from the same supplier. Sonication was conducted
with a 50 Sonic dismembrator probe sonicator from Fisher
Scientific. Fluorescence spectroscopy was conducted using
a Quanta-Master QM-1 fluorometer from Photon Technol-
ogies Inc., with the resulting data analyzed with software
provided by the same manufacturer (Felix software ver.
1.1, 1996 PTI, Inc.). Cylindrical, UV-transparent micro-
cuvettes (6-mm outside diameter) used for fluorescence
measurements were obtained from Sienco. High-speed
centrifugation of small-volume samples was conducted in
a TLA-100 ultracentrifuge from Beckman, with centrifu-
gation tubes and the TLA-100.2 rotor supplied from the
same manufacturer.
2.2. Purification of mAb 44.1
Prior to labeling with CCB, mAb 44.1 was purified on a
GammaBind affinity matrix. For purification, f 1 ml of
GammaBind beads was first rinsed with 5 ml of 0.5 M
acetic acid, pH 3.0, and then equilibrated by washing
extensively with PBS (10 mM NaH2PO4/100 mM NaCl,
pH 7.3). Hybridoma culture supernatant (500 ml) was then
tumbled with the beads at 4 jC overnight and the column
was successively washed with 20 ml PBS, followed by 10
ml PBS/0.5 M NaCl and finally 20 ml of 10 mM PBS. The
antibodies were eluted from the GammaBind matrix by
addition of 0.5 M acetic acid (pH 3.0), with 500-Al elution
fractions collected directly into 400 Al of 1 M Tris, pH 9.0.
Antibody eluted from the matrix was detected by absorptionspectroscopy, pooled and dialyzed against four changes of
2000 volumes of PBS at 4 jC. Following dialysis, antibody-
containing solutions were concentrated to f 1 ml in a
Centricon-30 concentrator and final protein concentration
determined using the BCA method.
2.3. CCB labeling of mAb 44.1
mAb 44.1 was labeled under neutral pH conditions
where acetyl azide compounds preferentially react with
the N-termini of both the heavy and light chains of mouse
IgG molecules [29]. For labeling, a 50-fold molar excess of
CCB acetyl azide (dissolved as a 10 mM stock in methanol)
was added to the antibody and the resulting mixture
tumbled for 48 h at 4 jC. The reaction was terminated by
addition of 100 mM hydroxylamine, pH 8.5, and free dye
removed by chromatography on Bio-Rad P-10 desalting
columns (equilibrated in PBS) with eluted antibody
detected by absorption spectroscopy. The resulting, labeled
antibody was pooled and further dialyzed against three
changes of 2000 volumes of PBS. For determination of
labeling stoichiometry, protein content was determined by
the BCA method and CCB quantitated by absorbance
spectroscopy using e400 = 31,400 M
 1 cm 1 (obtained
from Molecular Probes). This particular procedure resulted
in a labeling stoichiometry of f 5.7:1 CCB/mAb 44.1.
Since the absolute degrees of both fluorescence quenching
and relaxation depend on the overall labeling stoichiometry
(data not shown) and the particular residues that are
covalently modified, results obtained with a single batch
of CCB-labeled mAb 44.1, labeled as described above,
were used when comparing relative relaxation of fluores-
cence quenching (Table 1) to enable direct comparison of
the various lipids and amphiphiles.
Alternatively, production of CCB-mAb 44.1 with a
similar labeling stoichiometry was carried out by addition
of a 40-fold molar excess of CCB acetyl azide to the
antibody (0.5 mg of mAb 44.1 in 400-Al PBS), with the
resulting mixture tumbled for 1.5 h at room temperature.
The reaction was terminated by addition of 75 mM Tris, pH
7.4 and free dye was removed by chromatography on Bio-
Rad P-10 desalting columns (equilibrated in PBS) with
eluted antibody detected by absorption spectroscopy. The
resulting, labeled antibody was pooled and further dialyzed
against 2000 volumes of PBS. Antibody labeled by this
procedure was used primarily to obtain titration data with
the various PA species and to analyze the effects of AA-ME
on relaxation of fluorescence quenching induced by 10:0 PA
and DOPA.
2.4. Purification of flavocytochrome b
Construction of the mAb 44.1 affinity matrix and
immunoaffinity purification of Cyt b from neutrophil
plasma membranes was conducted as previously described
[9]. For removal of elution peptide following purification,
Table 1
Anionic amphiphiles and phospholipids induce conformational changes in
detergent-solubilized flavocytochrome b
Lipid species examined Relative relaxation
of fluorescence
quenchinga
Apparent Kd
(AM)
Lithium dodecyl sulfate (LDS) 1.0 51F14 (n= 6)
Arachidonic acid 0.85 116F 8 (n= 3)
18:1 Phosphatidic acid (DOPA) 0.83 14F 5 (n= 5)
10:0 Phosphatidic acid 0.68 18F 1 (n= 3)
18:1 Phosphatidylserine
(DOPS)
0.39 not determined
8:0 Phosphatidic acid 0.34 21F 4 (n= 5)
18:1 Phosphatidylethanolamine
(DOPE)
no relaxation
observed
18:1 Phosphatidylcholine
(DOPC)
no relaxation
observed
18:1 Diacylglycerol no relaxation
observed
8:0 Diacylglycerol no relaxation
observed
Arachidonate methyl ester no relaxation
observed
Following complex formation between CCB-mAb 44.1 and immunoaffi-
nity-purified flavocytochrome b, the effects of a panel of lipid species on
donor fluorescence were examined. The saturable relaxation of fluorescence
quenching observed with various anionic amphiphiles and phospholipids
represents conformational changes in flavocytochrome b.
a Since LDS gave the greatest observed relaxation, this value was
given a value of 1 and the relaxation induced by other anionic lipids is
reported relative to that observed with LDS. Results were obtained with a
single batch of CCB-mAb 44.1 to facilitate direct comparison of the
various lipids examined in this study. Analyses were conducted in at least
triplicate and independent experiments with individual lipids were in
agreement to within F 5%.
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mately 1 ml in a Centricon-50 concentrator and then
dialyzed (with one change of buffer) against 1000 volumes
of 50 mM K2HPO4/150 mM NaCl/1 mM EGTA/1 mM
MgCl2 (pH 7.3) overnight at 4 jC. Prior to RET studies,
Cyt b was centrifuged at 108,000 g for 30 min in a TLA
100.2 rotor. Final Cyt b concentration was determined by
absorption spectroscopy using e414 = 131,000 M
 1 cm 1
[30].
2.5. Preparation of lipid stock solutions
Phospholipids, DAGs, AA and AA-ME were stored in
chloroform at  20 jC in sealed containers after briefly
purging with argon. For preparation of working stock
solutions, the appropriate amount of lipid was transferred
to a boroscillate glass tube and samples were vortexed under
a stream of argon for removal of the chloroform. Lipids
were resuspended to a final concentration of 2.5 mM by
addition of an appropriate amount of filtered PBS/1% DDM
and then dispersed by vortexing and brief probe sonication.
The LDS and deoxycholate working solutions (2.5 mM)
were prepared in PBS and filtered prior to use. All lipid
working solutions were used fresh on the day of preparation.2.6. Fluorescence resonance energy transfer studies
Solutions containing Cyt b and CCB-labeled antibodies
were kept on ice prior to use while lipid stock solutions were
stored at room temperature. Fluorescence measurements
were conducted in continuously stirred, UV-transparent
microcuvettes at room temperature with the excitation
monochromator set at 376 nm and the emission monochro-
mator set at 418 nm. The slit width for both monochroma-
tors was set at 2 nm, corresponding to 4- and 8-nm bandpass
for the excitation and emission monochromators, respec-
tively. Experimental concentrations of both CCB-mAb 44.1
and Cyt b were well below the level where any significant
inner-filter effects would occur (A376 < 0.001 AU for both
CCB and Cyt b).
For fluorescence measurements, CCB-labeled antibody
was diluted to 10 nM in PBS/0.03% DDM and filtered prior
to use. After background fluorescence had been established
with a filtered solution of PBS/0.03% DDM (in a separate
cuvette), fluorescence of the labeled antibody was moni-
tored for a short time prior to addition of other agents.
Flavocytochrome b (typically 30 nM final) was added
directly to the stirred microcuvette and fluorescence emis-
sion monitored until a steady state was achieved. Lipids and
amphiphiles were then added directly to the microcuvettte
and fluorescence emission again monitored until a steady
state was achieved. All experiments were conducted at least
in triplicate and were generally reproducible to within F 5%
of the observed relaxation of fluorescence quenching when
comparing a single batch of CCB-mAb 44.1. For analysis of
the effects of AA-ME on the relaxation of fluorescence
quenching induced by 10:0 PA and DOPA, AA-ME was
added to the CCB-mAb 44.1 stock solution prior to the
addition of Cyt b and anionic lipids.
Titration curves were obtained for determination of ap-
parent dissociation constants for the anionic lipids AA, LDS,
8:0 PA, 10:0 PA and DOPA, with the absolute values of
fluorescence change fit to a one-phase exponential associa-
tion curve by nonlinear regression using the equation
Y= Ymax(1 e kx), where Ymax represents fluorescence at
saturation of the quenching effect. All curve-fitting analyses
were performed using GraphPad Prism version 3.02 soft-
ware. Apparent Kd values for the various anionic lipids are
provided with the understanding that such lipids may parti-
tion and disperse into DDM micelles to various extents,
creating an undefined effective local concentration for Cyt b.
2.7. Control experiments ensuring that lipids do not
dissociate the CCB-mAb 44.1:Cyt b complex, do not alter
donor fluorescence and do not alter the Cyt b heme spectrum
To ensure that the various lipids and amphiphiles did not
significantly dissociate the CCB-mAb 44.1:Cyt b complex,
immunoprecipitation experiments were conducted and Cyt b
content of the resulting supernatant fractions assessed by
absorption spectroscopy. For immunoprecipitation experi-
ysica Acta 1663 (2004) 201–213
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added to PBS/0.03% for a final volume of 1.65 ml and
rotated at room temperature for 5 min. Following this
incubation, 200 Al of the above mixture was added to 50
Al of packed GammaBind Plus-Sepharose beads (that had
been previously equilibrated in PBS) and the resulting
mixtures rotated for 15 min at room temperature. Lipids
and amphiphiles examined in RET studies were next added
to the above samples at a final concentration of 150 AM and
the resulting samples rotated for 10 min at room tempera-
ture. The GammaBind beads were then pelleted by brief
centrifugation and resulting supernatant fraction analyzed
for Cyt b content by absorption spectroscopy. Total Cyt b in
these samples was determined by a similar experiment
where protein was incubated with the GammaBind beads
in the absence of CCB-mAb 44.1.
To ensure that the phospholipids and amphiphiles exam-
ined in this study did not significantly alter the steady state
fluorescence of CCB-mAb 44.1, donor fluorescence was
monitored following addition of these agents in the absence
of Cyt b. To ensure that the phospholipids and amphiphiles
examined in this study did not significantly alter the Cyt b
Soret absorbance band, immunoaffinity-purified Cyt b was
exposed to these agents (150 AM) for 5 min at room
temperature and then analyzed by absorption spectroscopy.3. Results
3.1. CCB-mAb 44.1 is a specific donor for RET studies with
Cyt b heme acceptors
In the interest of generating a defined, site-specific probe
for exploring conformational changes in flavocytochrome b
by RET methods, the Cyt b-specific mAb 44.1 [31] was
labeled with the fluorescent donor CCB [32]. Covalent
modification of mAb 44.1 under the outlined conditions
resulted in a labeling stoichiometry of f 5.7 mol CCB:1Fig. 1. Fluorescence quenching from RET following the specific and
saturable association of CCB-mAb 44.1 and immunoaffinity-purified
flavocytochrome b. Following covalent modification of the epitope-mapped,
Cyt b-specific mAb 44.1 with Cascade Blue acetyl azide, the utility of this
fluorescence donor was examined in RET studies with immunoaffinity-
purified flavocytochrome b. (A) The absorption spectrum of CCB-mAb 44.1
(20-fold dilution of stock solution) showing the absorption band at 400 nm
used to calculate the CCB content of labeled fractions. Protein content of this
fraction was estimated by the BCA method for determination of a labeling
stoichiometry of f 5.7:1 CCB/mAb 44.1 (molar ratio). (B) The saturable
decrease in the steady state fluorescence of CCB-mAb 44.1 (10 nM CCB-
mAb final representing 20 nM Cyt b binding sites) resulting from complex
formation following equimolar additions of immunoaffinity-purified
flavocytochrome b (10 nM Cyt b in the fluorescence cuvette at each
addition). Arrows indicate the timepoints at which Cyt b was added to the
fluorescence cuvette containing CCB-mAb 44.1. (C) The relaxation of
fluorescence quenching observed following addition of the epitope
mimicking peptide, AC-PQVRPI-CONH2. Arrows indicate the addition of
both Cyt b (30 nM final) and AC-PQVRPI-CONH2 (250 AM additions) to
the fluorescence cuvette containing CCB-mAb 44.1 (10 nM).mol mAb 44.1 (Fig. 1A). Western blot analysis using an
anti-CCB polyclonal antibody demonstrated the incorpora-
tion of label on both the heavy and light chains of mAb 44.1
(data not shown).
To examine both the activity of mAb 44.1 following CCB
modification and the utility of this reagent for RET measure-
ments, the fluorescence emission of CCB-mAb 44.1 (10 nM)
was monitored following addition of immunoaffinity-puri-
fied Cyt b (10 nM final Cyt b in the fluorescence cuvette
following each addition; Ref. [9] shows a representative
SDS-PAGE gel demonstrating the high degree of purity of
Cyt b used in this study). As observed in Fig. 1B, addition of
Cyt b resulted in quenching of CCB fluorescence with
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of a twofold molar excess of Cyt b (40 nM) relative to the
total concentration of CCB-mAb 44.1 binding sites (10 nM
CCB-mAb 44.1 represents a 20 nM concentration of binding
sites assuming that both variable regions associate with Cyt
b). Western blot analysis confirmed that the activity of mAb
44.1 was not appreciably compromised following covalent
modification (data not shown).
Previous studies have shown the epitope-mimicking
peptide AC-PQVRPI-CONH2 to potently dissociate the
Cyt b-mAb 44.1 complex [31]. To confirm the specificity
of the complex formed between purified Cyt b and CCB-
mAb 44.1 under the conditions of our RET measurements,
the effects of AC-PQVRPI-CONH2 on the observed fluo-
rescence quenching were investigated. Addition of the
epitope-mimicking peptide (250 AM) resulted in disruption
of the Cyt b–antibody complex as judged by the rapid
relaxation of fluorescence quenching (Fig. 1C). A subse-
quent addition of peptide had minimal effect, indicating
saturation of the observed fluorescence relaxation. Specific-
ity of the interaction between CCB-mAb 44.1 and Cyt b was
also demonstrated by the lack of fluorescence quenching
observed upon addition of Cyt b in the presence of a 25-fold
molar excess of unlabeled antibody (data not shown).
3.2. Conformational changes in DDM-solubilized flavocy-
tochrome b are induced by the anionic amphiphiles LDS
and AA
The anionic amphiphiles LDS and AA have long been
used for activation of the NADPH oxidase complex in cell-
free assay systems [33,34] and previous studies have dem-
onstrated the ability of these agents to induce structural
changes in flavocytochrome b [25,26]. To characterize the
effects of these anionic amphiphiles in our RET system,
LDS and AA were introduced into the system following
formation of the CCB-mAb 44.1:Cyt b complex. Fig. 2A
shows the relaxation in fluorescence quenching observedFig. 2. The anionic amphiphiles AA and LDS induce conformational
changes in immunoaffinity-purified flavocytochrome b. After formation of
the CCB-mAb 44.1:Cyt b complex, steady state fluorescence was
monitored following addition of AA, LDS or AA-ME. (A) The saturable
relaxation of fluorescence quenching observed when AA was added the
CCB-mAb 44.1:Cyt b complex. Arrows indicate the addition of both Cyt b
(30 nM final) and AA (50 AM additions) to the fluorescence cuvette
containing CCB-mAb 44.1 (10 nM). (B) Representative analysis of titration
curves obtained with the anionic amphiphile AA. The apparent Kd for AA
was calculated to be 116F 8 AM (n= 3), while similar analysis of the
anionic amphiphile LDS (data not shown) indicated an apparent Kd of
51F14 AM (n= 6). (C) The relaxation of fluorescence quenching observed
when LDS was added the CCB-mAb 44.1:Cyt b complex. Arrows indicate
the addition of both Cyt b (30 nM final) and LDS (100 AM final) to the
fluorescence cuvette containing CCB-mAb 44.1 (10 nM). The observed
relaxation in fluorescence quenching was fully saturated at this level of
LDS. (D) The lack of observable fluorescence quenching when AA-ME
was added the CCB-mAb 44.1:Cyt b complex. Arrows indicate the addition
of both Cyt b (30 nM final) and AA-ME (100 AM additions) to the
fluorescence cuvette containing CCB-mAb 44.1 (10 nM).
Fig. 3. Control experiments confirming that amphiphile-induced relaxation
of fluorescence quenching results from conformational changes in
flavocytochrome b. The following control experiments were conducted to
examine the effects of AA, LDS and AA-ME on various components of the
RET assay. (A) AA (100 AM additions) has no effect on the steady state
fluorescence of CCB-mAb 44.1. Similar results were observed for LDS and
arachidonate ethyl ester. (B) Addition of AA (150 AM final) does not lead
to appreciable dissociation of the CCB-mAb 44.1:Cyt b complex as
measured by immunoprecipitation of Cyt b. Curve a (—), supernatant
absorption following incubation of Cyt b and GammaBind beads in the
absence of CCB-mAb 44.1 (total Cyt b); Curve b (—), supernatant
absorption following immunoprecipitation of Cyt b by CCB-mAb 44.1;
Curve c (), supernatant absorption following immunoprecipitation of Cyt
b by CCB-mAb 44.1 in the presence of AA; Curve d (– – – ), supernatant
absorption following immunoprecipitation of Cyt b by CCB-mAb 44.1 in
the presence of DOPA (see Results, Fig. 5). Similar results were obtained
for LDS and AA-ME. (C) The Soret absorption spectrum of immunoaf-
finity-purified Cyt b (Curve a; —) is not altered in the presence of 150 AM
AA (Curve b; – – – ). Similar results were obtained for LDS and AA-ME.
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added to the CCB-mAb 44.1:Cyt b complex. The effect of
AA was saturable and resulted in maximal relaxation of
fluorescence quenching at levels commonly employed for
maximal activation of the NADPH oxidase complex in cell-
free assays (f 150 AM AA). Analysis of titration curves
(Fig. 2B) indicated an apparent Kd of 116F 8 AM (n = 3) for
AA under these assay conditions. Similar results were
observed for the anionic amphiphile LDS, with maximal
relaxation of fluorescence quenching occurring when this
agent was added at f 100 AM (Fig. 2C). Analysis of
titration curves indicated an apparent Kd of 51F14 AM
(n = 6) for LDS under these assay conditions (data not
shown). In contrast to LDS and AA, no significant relaxa-
tion of fluorescence quenching was observed upon addition
of similar concentrations of the compound AA-ME (Fig.
2D) or the anionic amphiphile deoxycholate (data not
shown). Table 1 summarizes results obtained with LDS,
AA and AA-ME.
3.3. Anionic amphiphiles do not dissociate the CCB-mAb
44.1:Cyt b complex, do not perturb CCB-mAb 44.1
fluorescence and do not alter the Cyt b absorbance
spectrum
To rule out a trivial explanation of our observed RET
results, control experiments were conducted to explore
effects of the above agents on: (1) the baseline fluorescence
of CCB-mAb 44.1; (2) the association state of the CCB-
mAb 44.1:Cyt b complex; and (3) the Soret absorbance
spectrum of affinity-purified Cyt b. Fig. 3A shows no
observable change in the fluorescence emission of CCB-
mAb 44.1 following addition of AA at levels which resulted
in significant relaxation of fluorescence quenching of the
CCB-mAb 44.1:Cyt b complex. Similar results were ob-
served with both LDS and AA-ME (data not shown) and
rule out the possibility that the observed relaxation of
fluorescence quenching in the presence of Cyt b was due
to direct effects of these amphiphiles on the labeled antibody
itself. To ensure that the amphiphiles AA and LDS did not
dissociate the CCB-mAb 44.1:Cyt b complex (resulting in
physical separation of the fluorescence donor–acceptor
pair), immunoprecipitation experiments were conducted in
the presence and absence of these agents. Such experiments
indicated that addition of AA (Fig. 3B), LDS and AA-ME
(data not shown) resulted in no significant dissociation of
the CCB-mAb 44.1:Cyt b complex, similarly ruling out this
possible effect as a cause for the observed relaxation of
fluorescence quenching in these RET studies. Since an
alteration in the spectral overlap between CCB and the
Cyt b Soret spectrum might also account for the observed
relaxation in fluorescence quenching, the effects of AA,
LDS and AA-ME on the Cyt b Soret absorbance spectrum
were characterized. Fig. 3C demonstrates that AA has no
effect on the nature of the Cyt b Soret band, eliminating
such effects as a possible explanation for the results ob-
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both LDS and AA-ME (data not shown).
In light of results obtained in the above control experi-
ments, we conclude that the observed relaxation in fluores-
cence quenching indicates an increase in the distance
between the fluorescence donor (CCB) and the Cyt b heme
prosthetic groups and/or a significant alteration of the
relative orientation of the Cyt b heme prosthetic groups
and CCB. Consistent with previous studies [25,26], these
results demonstrate the ability of anionic amphiphiles to
induce conformational changes in flavocytochrome b. The
lack of relaxation in fluorescence quenching in the presence
of AA-ME is supported by studies demonstrating the
inability of this agent to induce conformational changes in
Cyt b [25,26].
3.4. Structural changes in DDM-solubilized flavocyto-
chrome b are induced by PA species
The involvement of both phospholipase D and PA in the
regulation of the NADPH oxidase complex [12,21] raises
the possibility that, in addition to previously characterized
roles in signal transduction, PA also acts directly at the level
of flavocytochrome b. To characterize the effects of PA on
the structure of flavocytochrome b, different PA species
were introduced into the RET assay following formation of
the CCB-mAb 44.1:Cyt b complex. Fig. 4A and B demon-
strates the observed relaxation in fluorescence quenching
when the CCB-mAb 44.1:Cyt b complex was exposed to
8:0 PA (100 AM additions) or DOPA (18:1 PA; 25 AM
additions). Although a kinetically slower process is ob-
served with the long-chain PA species, a greater degree of
relaxation was achieved with DOPA than with its 8:0
analog. Similar analysis with 10:0 PA demonstrated that
this lipid also resulted in relaxation of the observed fluo-
rescence quenching (data not shown), while the phospho-
lipid 18:0 PA proved too insoluble to obtain consistentFig. 4. PA species induce conformational changes in immunoaffinity-
purified flavocytochrome b. Following formation of the CCB-mAb
44.1:Cyt b complex, steady state fluorescence was monitored following
addition of 8:0 PA or DOPA (18:1 PA). (A) The relaxation of fluorescence
quenching observed when the CCB-mAb 44.1:Cyt b complex is exposed to
8:0 PA. Arrows indicate the addition of both Cyt b (30 nM final) and 8:0 PA
(100 AM additions) to the fluorescence cuvette containing CCB-mAb 44.1
(10 nM). (B) The saturable nature of the relaxation of fluorescence
quenching observed when the CCB-mAb 44.1:Cyt b complex is titrated
with DOPA. Arrows indicate the addition of both Cyt b (30 nM final) and
DOPA (25 AM additions) to the fluorescence cuvette containing CCB-mAb
44.1 (10 nM). (C) Representative analysis of titration curves obtained with
the anionic phospholipid DOPA. The apparent Kd for DOPAwas calculated
to be 14F 5 AM (n= 5), while similar analysis of the anionic phospholipids
8:0 PA and 10:0 PA (data not shown) indicated an apparent Kd of 21F 4
AM (n= 5) and 18F 1 AM (n= 3), respectively. (D) The relaxation of
fluorescence quenching observed when the CCB-mAb 44.1:Cyt b complex
is exposed to 18:1 PA (10 nM final) in the absence (Curve A) and presence
(Curve B) of a 20-fold molar excess of AA-ME. Arrow indicates the
addition of DOPA to the fluorescence cuvette following formation of the
CCB-mAb 44.1:Cyt b complex.
Fig. 5. Control experiments confirming that PA-induced relaxation of
fluorescence quenching results from conformational changes in flavocyto-
chrome b. The following control experiments were conducted to examine
the effects of PA species on various components of the RET assay. (A)
Demonstration that DOPA (100 AM additions) has no effect on the steady
state fluorescence of CCB-mAb 44.1. Similar results were observed for all
phospholipids and DAGs examined in this study. (B) The Soret absorption
spectrum of immunoaffinity-purified Cyt b (Curve a; —) is not altered in
the presence of 150 AM DOPA (Curve b; – – – ). Similar results were
obtained for all lipids examined in this study. See Fig. 3B for a
demonstration that DOPA (150 AM final) does not lead to appreciable
dissociation of the CCB-mAb 44.1:Cyt b complex. Similar results were
obtained for all phospholipids and DAGs examined in this study.
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indicated apparent Kd values of 21F 4 AM (n = 5) for 8:0
PA, 18F 1 AM (n = 3) for 10:0 PA and 14F 5 AM for
DOPA (Fig. 4C) under these assay conditions. Table 1
summarizes results obtained with 8:0 PA, 10:0 PA and
DOPA.
Since AA-ME has previously been shown to competi-
tively inhibit both anionic amphiphile-induced activation of
the NADPH oxidase complex and conformational changes
in Cyt b [25,26], the effects of AA-ME on PA-induced
conformational changes in Cyt b were also examined in this
study. In these experiments, the effects of 10:0 PA and
DOPA (10 AM final) on the CCB-mAb 44.1:Cyt b complex
were analyzed in the presence and absence of a 20-fold
molar excess of AA-ME (200 AM final). Results obtained
under these experimental conditions indicated that the
presence AA-ME diminishes the relaxation of fluorescence
quenching induced by both 10:0 PA (20F 2% relaxation
(n = 5) in the absence of AA-ME; 12F 2% relaxation (n = 6)
in the presence of AA-ME) and DOPA (Fig. 4D; 32F 6%
relaxation (n = 6) in the absence of AA-ME; 10F 3%
relaxation (n= 6) in the presence of AA-ME).
Similar to results obtained with the anionic amphiphiles,
control experiments indicated that DOPA: (1) had no
significant effect on the fluorescence emission of CCB-
mAb 44.1 (Fig. 5A); (2) did not appreciably dissociate the
CCB-mAb 44.1:Cyt b complex (see Fig. 3B); and (3) had
little effect on the nature of the Cyt b Soret absorbance
spectrum (Fig. 5B). Similar results were obtained in control
experiments conducted with 8:0 PA and 10:0 PA (data not
shown). The above results indicate that the various PA
species examined were able to directly induce conforma-
tional changes in purified flavocytochrome b in a structure-
specific fashion.
3.5. Structural changes in DDM-solubilized flavocyto-
chrome b are specifically induced by anionic phospholipids
The observation that a variety of PA species were
capable of inducing conformational changes in flavocyto-
chrome b raises the question of whether such effects are
lipid-species-specific or simply a general property of phos-
pholipids under such assay conditions. To examine the
specificity of phospholipids for inducing structural changes
in Cyt b, a panel of synthetic 18:1 phospholipids with
different headgroups was examined in our RET system. Fig.
6A–D shows the effects of the phospholipids DOPA,
DOPS, DOPC and DOPE when added to the CCB-mAb
44.1:Cyt b complex. Such analysis demonstrates that expo-
sure to DOPA results in the most dramatic relaxation of
fluorescence quenching (Fig. 6A), while the phospholipid
DOPS induces a more modest conformation change in Cyt
b (Fig. 6B) as determined by this specific assay system. In
contrast, addition of similar concentration of either DOPC
(Fig. 6C) or DOPE (Fig. 6D) resulted in no observable
relaxation of fluorescence quenching. Table 1 summarizesresults obtained with the 18:1 phospholipids DOPA, DOPS,
DOPC and DOPE.
Since previous reports have demonstrated the ability of
both short-chain PA and short-chain DAG to individually
support modest activation of the NADPH oxidase complex
[35], the ability of both 8:0 and 18:1 DAG to induce
conformational changes in Cyt b was also examined. In
contrast to results obtained with PA species, exposure of the
CCB-mAb 44.1:Cyt b complex to similar levels of 8:0 DAG
(data not shown) or 18:1 DAG (Fig. 6E) resulted in no
significant relaxation of fluorescence quenching. Previous
observations that a combination of short-chain PA and DAG
species resulted in synergistic activation of superoxide
production [35] led us to examine the effects of DAG on
titration curves conducted with DOPA. In these experi-
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to 100 AM levels of either 8:0 or 18:1 DAG resulted in no
significant alteration of the titration curve conducted withFig. 6. The effect of headgroup on phospholipid-mediated conformational
changes in immunoaffinity-purified flavocytochrome b. To examine the
specificity of PA for inducing conformational changes in flavocytochrome
b, a variety of 18:1 lipids were evaluated for their effect on the CCB-mAb
44.1:Cyt b complex. (A and B) The relaxation in fluorescence quenching
when the CCB-mAb 44.1:Cyt b complex is exposed to DOPA and DOPS,
respectively. In contrast, no significant relaxation in fluorescence quenching
is observed in similar studies conducted with DOPC (C), DOPE (D) or 18:1
DAG (E). Arrows indicate the addition of both Cyt b (30 nM final) and
lipids (100 AM additions) to the fluorescence cuvette containing CCB-mAb
44.1 (10 nM).
Fig. 6 (continued).DOPA (data not shown). Table 1 summarizes results
obtained with 8:0 and 18:1 DAG.
As described for the other lipids and amphiphiles exam-
ined (see Figs. 3 and 5), control experiments conducted with
DOPS, DOPC, DOPE and DAG species similarly ruled out
a trivial explanation for the observed results obtained in our
energy transfer measurements (data not shown). Such results
demonstrate the specificity of particular phospholipids for
inducing structural rearrangements in detergent-solubilized
flavocytochrome b, with long-chain PA species causing the
most dramatic relaxation in fluorescence quenching under
our assay conditions.4. Discussion
4.1. CCB-mAb 44.1 as a probe for RET studies with
flavocytochrome b
Cascade Blue acetyl azide is an amine-reactive, fluores-
cent compound that has a relatively high extinction coeffi-
cient and an emission spectrum with optimal overlap of the
Cyt b Soret absorbance band. Using cytochrome c as a test
case, the utility of CCB as a fluorescence donor for
analyzing the structure and conformational dynamics of
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demonstrated [36]. Initial efforts to apply such methods for
the structure analysis of flavocytochrome b involved the
generation of a CCB-labeled WGA conjugate which specif-
ically bound the Cyt b N-linked glycan moieties. This
system was used to demonstrate that detergent-solubilized
Cyt b undergoes significant conformational changes in the
presence of the anionic amphiphiles LDS and AA [26].
In the present study, we have extended results obtained
with the CCB-WGA conjugate by labeling the Cyt b-
specific, epitope-mapped mAb 44.1 [31] with CCB and
examining a panel of amphiphiles and phospholipids for the
ability to induce conformational changes in detergent-solu-
bilized flavocytochrome b. Additionally, the Cyt b sample
used in the present RET studies was generated by a recently
described immunoaffinity purification method [9] that
results in a more highly purified preparation than previously
employed. CCB-mAb 44.1 bound to Cyt b with high
specificity and affinity, providing a more defined probe
for conducting energy transfer studies than the WGA
conjugate.
Although a valuable reagent for demonstrating lipid and
amphiphile-induced conformational changes in Cyt b,
obtaining accurate distance measurements from the mAb
44.1 epitope to the Cyt b heme prosthetic groups by our
current RET measurements is complicated by the fact that
we have not precisely identified the specific mAb 44.1
residues labeled by CCB. Since acetyl azide compounds
have been shown to selectively modify the N-termini of
monoclonal IgG molecules under neutral pH conditions
[29], current efforts are being directed at the generation of
Fab fragments from various Cyt b-specific, epitope-mapped
monoclonal antibodies, selectively labeled with CCB at
their N-termini, as highly defined probes for estimating
distances between antibody epitopes and the Cyt b heme
prosthetic groups.
4.2. The anionic amphiphiles LDS and AA modulate the
conformation of flavocytochrome b
The anionic amphiphiles LDS and AA have long been
employed to promote activation of the NADPH oxidase
complex in in vitro assays of superoxide production [33,34].
RET measurements conducted in this study demonstrated
the ability of LDS and AA to directly modulate the
conformation of detergent-solubilized flavocytochrome b
when introduced at levels where maximum activation of
the NADPH oxidase complex is observed in vitro. The
selectivity of these agents is further supported by the
inability of the irrelevant anionic amphiphile deoxycholate
or AA-ME to induce the dramatic relaxation of fluorescence
quenching. These results are in accordance with a growing
body of literature [25,26,37,38] supporting the contention
that such anionic amphiphiles induce structural rearrange-
ments in flavocytochrome b relevant to activation of the
NADPH oxidase complex. From a structural perspective, itis of interest to highlight a recent study by our group using
CCB-labeled WGA that demonstrated a similar profile of
relaxation of fluorescence quenching upon exposure to AA
and LDS [26]. Since WGA binds the extracellular N-linked
glycan moieties on gp91phox while mAb 44.1 recognizes an
epitope residing on the cytoplasmic portion of p22phox, the
energy transfer studies suggest that Cyt b conformational
changes are both substantial and global in nature. Combined
with observations implicating PLA2-generated AA as an in
vivo regulator of superoxide generation by the NADPH
oxidase complex [39], the above data support the hypothesis
that AA modulates the conformation of flavocytochrome b
in a physiologically relevant manner to promote superoxide
production.
4.3. Anionic phospholipids modulate the conformation of
flavocytochrome b
The role of particular phospholipids in facilitating a
catalytically active state of the NADPH oxidase complex
has received considerable attention [4,10,20,35,40,41]. In
the present study we demonstrate, for the first time, that
both PA and phosphatidylserine are capable of directly
modulating the conformation of flavocytochrome b. The
long-chain, unsaturated phospholipid DOPA was observed
to induce structural changes in DDM-solubilized Cyt b to a
similar degree as AA, and appeared to be a more potent
agent, as lower concentrations of DOPA were required to
saturate the observed fluorescence relaxation. The anionic
phospholipid DOPS also induced structural changes in
DDM-solubilized Cyt b, although to a lesser extent than
DOPA or AA. The relaxation induced by DOPA and DOPS
was observed to be a kinetically slower process than
observed for LDS, AA and short-chain PA species. These
results might indicate a slower on-rate for binding of 18:1
phospholipids or may simply indicate that the 18:1 phos-
pholipids require a longer period of time to disperse into Cyt
b-containing DDM micelles.
The ability to induce such conformational changes in Cyt
b appears to be mediated, in part, by an anionic lipid
headgroup, as uncharged phospholipids of identical acyl
chain composition were unable to produce the same effect.
This behavior is consistent with the observed requirement
for the anionic carboxylate group of AA for inducing
conformational changes in flavocytochrome b (the neutral
derivative AA-ME is inactive; [25,26]) and suggests charge
to be an important criteria for association of lipid with
flavocytochrome b. Consideration of both the lipid compo-
sition of neutrophil membranes [42] and the rapid activation
of phospholipase D following cell stimulation [43] makes
the ability of DOPA to potently induce structural rearrange-
ment in DDM-solubilized Cyt b of particular interest. It is
also important to note that the 18:1 acyl chain (found in
DOPA) has been demonstrated to be a highly abundant
constituent of neutrophil membrane phospholipids [42].
Thus, it appears that long-chain, unsaturated PA species
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regulators of Cyt b conformation. In the neutrophil mem-
brane, anionic lipids might serve to support conformations
of Cyt b that allow association with oxidase cytosolic
factors and/or allow efficient electron transfer. Although a
difficult task, it will be of particular interest to directly
demonstrate specific binding of anionic phospholipids and
amphiphiles to Cyt b and to characterize the structural
features of this integral membrane protein that mediate such
binding. Preliminary studies demonstrating the ability of
AA-ME to diminish PA-induced conformational changes in
DDM-solubilized Cyt b raise the possibility that diverse
lipids share a common or partially overlapping binding site
on Cyt b.
In light of our current observations, it is also important to
highlight previous studies demonstrating that PA and DAG
both activate superoxide production by directly interacting
with components of the NADPH oxidase complex [20].
Examination of DAG species by RET in the present study
indicated no ability of this lipid to induce conformational
changes in Cyt b or to potentiate the ability of DOPA to
induce structural rearrangements. These results do not rule
out the possibility that DAG specifically associates with Cyt
b to serve some sort of a regulatory role in superoxide
production.
4.4. Regulation of assembly and activation of the phagocyte
NADPH oxidase complex by lipid second messengers
Activation of phagocytes by a variety of different stimuli
results in the enzymatic remodeling of membrane phospho-
lipids and generation of second messenger species including
AA, DAG and PA [12]. A number of studies have demon-
strated both activation of superoxide production in a time
course that parallels the generation of the above molecules
and the ability of such lipid second messengers to directly
regulate assembly and activation of the NADPH oxidase
complex. The present study demonstrates the ability of the
second messenger lipids AA and PA to modulate the
conformation of the catalytic component of the NADPH
oxidase complex, raising the possibility that flavocyto-
chrome b serves as a physiologically relevant target for
regulation by these lipids in vivo. The complexity of lipid-
induced activation of superoxide production is highlighted
by studies demonstrating the ability of second messenger
lipids to directly act on multiple components of the NADPH
oxidase complex including flavocytochrome b (Refs. 25,26
and this study), p47phox [14–18] and Rac-GDI [13]. The
role of second messenger lipids in regulation of superoxide
production is further complicated by the ability of these
species to activate protein kinases responsible for phosphor-
ylation of oxidase components [12]. Complex regulation
involving a requirement for the simultaneous interaction of
second messenger lipids with both protein kinases and
multiple components of the NADPH oxidase complex might
be anticipated in light of the strict spatial and temporalrequirements for superoxide generation in a productive
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